Livanova Stock News

Virginia Retirement Systems ET AL acquired a new stake in shares of LivaNova PLC (NASDAQ:LIVN) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 20,800 shares of the companys stock, valued at approximately $1,647,000. Other institutional investors and hedge funds have also modified their []

LivaNova PLC (NASDAQ:LIVN) Director Daniel Jeffrey Moore sold 1,000 shares of LivaNova stock in a transaction on Wednesday, December 1st. The stock was sold at an average price of $81.73, for a total transaction of $81,730.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through []

Needham & Company LLC reaffirmed their buy rating on shares of LivaNova (NASDAQ:LIVN) in a report published on Friday, PriceTargets.com reports. The firm currently has a $119.00 price target on the stock. A number of other research analysts have also recently commented on the company. Robert W. Baird upped their price target on LivaNova from []

Stock analysts at The Goldman Sachs Group started coverage on shares of LivaNova (NASDAQ:LIVN) in a report issued on Friday, The Fly reports. The firm set a buy rating and a $108.00 price target on the stock. The Goldman Sachs Groups target price would indicate a potential upside of 31.26% from the stocks previous close. []

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) Annual Meeting taking place Decembe

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place Decemb

Cardiopulmonary Autotransfusion System is a sophisticated device with a remarkably effective design that provides autologous blood during surgical procedures. Autologous red blood cell salvage is a safe, reliable, and cost-effective technique of returning washed red blood cells to a patient.

Invesco Ltd. grew its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 11.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 85,512 shares of the companys stock after acquiring an additional 8,461 shares during the quarter. Invesco Ltd. owned 0.17% []

Viveve Medical (NASDAQ:VIVE) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Valuation & Earnings This table compares Viveve Medical and LivaNovas revenue, earnings per share (EPS) and valuation. []

Wedge Capital Management L L P NC lowered its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 4.8% in the 3rd quarter, Holdings Channel.com reports. The fund owned 120,918 shares of the companys stock after selling 6,054 shares during the period. Wedge Capital Management L L P NCs holdings in LivaNova were worth $9,575,000 at []

The Global Adult and Pediatric Hemoconcentrators Market, by Product Type (Adult Hemoconcentrators and Pediatric Hemoconcentrators), by End User (Hospital, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that Damien McDonald, Chief Executive Officer, will participate in discussions at the Piper …

LONDON--(BUSINESS WIRE)-- #cardiovascular--LivaNova PLC announced Damien McDonald, CEO, will participate in discussions at the Piper Sandler 33rd Annual Virtual Healthcare Conference on Dec. 1.

Global Transcatheter Aortic Valve Replacement (TAVR) Market Synopsis: DBMR team offers customization of Transcatheter Aortic Valve Replacement (TAVR) Market report according to the business needs. Contact sales team, who will guarantee to get a report that suits the necessities. The Market